Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
75 /100
HIGH RISK
Score updated Aug 28, 2026

ENVB — Enveric Biosciences, Inc. Dilution Risk Tracker

Track ENVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENVB — Get alerts when the score changes →

As of August 28, 2026, Enveric Biosciences, Inc. (ENVB) has a DilutionWatch DilutionScore of 75/100, rated HIGH dilution risk. Enveric Biosciences, Inc. has a market capitalization of $8.47M, 4.48M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $10.00M, ATM program capacity of $1.35M, 153.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
model est. 53%
💰 Capital Raise model 93%
• Critical: only 2.8 months cash remaining
• Active shelf registration ($10M, 118% of market cap)
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (75/100)
🔔 Track ENVB — Get forecast alerts →

Market Data

Market Cap$8.47M
Shares Outstanding4.48M
Float3.64M
Cash$2.92M
Debt$3.49M
Short InterestN/A

Institutional Holdings

10 institutional holders · 24.2K shares
#1 AdvisorShares Investments, LLC 17.0K shares
#2 UBS Group AG 2.9K shares
#3 Citigroup Inc. 2.3K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest19.1K
Days to Cover1.0
% of Float0.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2020-12-31
EFFECT EFFECT 2026-04-29
424B3 ATM 2026-04-29
S-3 SHELF 2026-04-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ENVB Dilution Snapshot

Enveric Biosciences, Inc. (ENVB) has a DilutionScore of 75/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ENVB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENVB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ENVB
ENVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.